DIA Japan L.L.C.

Showing 1 - 1 of 1 listings for DIA Japan L.L.C.

  1. May 28 2012

    Pharmaceutical companies applying for new drug approval in Japan are now required to satisfy the ICH-E14 guideline. The hallmark of the ICH-E14 guidance is the Thorough QT (TQT) Study, or its alternatives for drugs that do not lend themselves…

Can't find a DIA Japan L.L.C. conference? Add It!

Add New Event

If the DIA Japan L.L.C. conference you are looking for isn't listed here, use our conference submit form to add it to our database.

See a problem or have a suggestion? Send us feedback.

You are viewing DIA Japan L.L.C. conferences. Find even more conferences happening in top conference industries.
Advertisement

Conference Wag

What Do Other Hounds Like?

Advertisement